Circulatory system: Blood Flashcards

1
Q

Circulatory System: Functions

  • Circulatory system: heart, ___, & ___
  • Cardiovascular system: heart & ___
  • Hematology—study of ___

• Functions:
– Transport (O2, CO2, ___, ___, hormones, & ___ cells)

– Protection (___ cells, initiates ___)

– Regulation (___ balance, ___ pH stabilization, & ___ control)

A

Circulatory System: Functions

  • Circulatory system: heart, BVs, & blood
  • Cardiovascular system: heart & BVs
  • Hematology—study of blood

• Functions:
– Transport (O2, CO2, nutrients, wastes, hormones, & stem cells)

– Protection (immune cells, initiates clotting)

– Regulation (fluid balance, ECF pH stabilization, & temperature control)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Blood: Components & General Properties

  • Adults: ___ L of blood
  • ____ tissue: cells + matrix

– Plasma: ___ of blood (clear, light ___ fluid)

– Formed elements: cells & cell fragments (___, ___, & ___)

A

Blood: Components & General Properties

  • Adults: 4-6 L of blood
  • Liquid connective tissue: cells + matrix

– Plasma: matrix of blood (clear, light yellow fluid)

– Formed elements: cells & cell fragments (RBCs, WBCs, & platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood: Components & General Properties -know which cells fall into which category

• 7 kinds of formed elements
1) ____ (RBCs)

2) ___

____ (WBCs)

• Granulocytes (w/ granules)

3) ___
4) ___
5) ____

• Agranulocytes (w/out granules)

6) ____
7) ____

A

Blood: Components & General Properties -know which cells fall into which category

• 7 kinds of formed elements
1) erythrocytes (RBCs)

2) platelets

Leukocytes (WBCs)

• Granulocytes (w/ granules)

3) basophils
4) eosinophils
5) neutrophils

• Agranulocytes (w/out granules)

6) lymphocytes
7) monocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood Plasma

• ___ blood to separate components

– ___ heaviest, settle ___ (hematocrit)
• ~ ___% total volume (% of blood)

– ____ & ___
• ___% total volume

– ___
• remainder volume ~ __% • mixture of ___, ___, ___, ___, nitrogenous ___, hormones, & ___

A

Blood Plasma

Centrifuge blood to separate components

Erythrocytes heaviest, settle first (hematocrit)
• ~ 45% total volume (% of blood)

White blood cells & platelets
1% total volume

Plasma
• remainder volume ~ 55% • mixture of H2O, proteins, nutrients, electrolytes, nitrogenous wastes, hormones, & gases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood Plasma -know name in red and functions

• Plasma—___ portion of ___
– Serum: plasma without ___

3 major categories of plasma proteins:

–____: smallest & most abundant
• contribute to ___ & ___; influence blood ___ & ___

– ___ (α, β, γ ___) - carry stuff in blood like hormones - are antibodies

  • ___
  • provide ___ system functions

– ___ (could change and become something else)
• precursor of ___ - help form ____

A

Blood Plasma -know name in red and functions

• Plasma— liquid portion of blood
– Serum: plasma without fibroses

3 major categories of plasma proteins:

albumins: smallest & most abundant
• contribute to viscosity & osmolarity; influence blood pressure & flow

globulins (α, β, γ globulins) - carry stuff in blood like hormones - are antibodies

  • transporters
  • provide immune system functions

fibrinogen (could change and become something else)
• precursor of fibrin - help form blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood Plasma

  • Plasma proteins formed by ___ – (except ___ globulins … from plasma ___!)

• ___ compounds
– Free ___
– Nitrogenous ___ (urea)
• toxic end products of ___ • removed by ___

  • ___

– ___, vitamins, fats, ___, ___

  • Dissolved __, ___, & ___
    • ___

– Na+ = ___% of plasma ___

A

Blood Plasma

  • Plasma proteins formed by liver– (except γ globulins … from plasma cells!)

Nitrogenous compounds
– Free amino acids
– Nitrogenous wastes (urea)
• toxic end products of catabolism • removed by kidneys

  • Nutrients

glucose, vitamins, fats, cholesterol, minerals

  • Dissolved O2, CO2, & nitrogen
  • Electrolytes

– Na+ = 90% of plasma cation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Blood: Viscosity & Osmolarity

  • Viscosity—resistance of ___ to ___, b/c of ___ (more stuff that’s in there, the more viscous it is)

– ___ 4.5-5.5X as viscous as water
– ___ 2X as viscous as water

  • Osmolarity of blood—total molarity of ___ that cannot pass through ___

– if too high, blood ___ too much water, blood pressure ___
– if too low, too much water stays in ___ (___), blood pressure ___

  • optimum osmolarity achieved by regulation of ___, ___, & ___
  • colloid osmotic pressure (COP)
A

Blood: Viscosity & Osmolarity

  • Viscosity—resistance of fluid to flow, b/c of cohesion (more stuff that’s in there, the more viscous it is)

whole blood 4.5-5.5X as viscous as water
plasma 2X as viscous as water

  • Osmolarity of blood—total molarity of dissolved particles that cannot pass through BV wall

– if too high, blood absorbs too much water, blood pressure increases
– if too low, too much water stays in tissues (edema), blood pressure drops

  • optimum osmolarity achieved by regulation of Na+, proteins, & RBCs
  • colloid osmotic pressure (COP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Plasma Protein Deficiency

  • _____

– deficiency of ____ (___ or lack of dietary ___ —- ___ or ___ disease)

  • Kwashiorkor

– in children w/ severe ___
• fed on cereals once weaned (____)

A

Plasma Protein Deficiency

  • Hypoproteinemia

– deficiency of plasma proteins (starvation or lack of dietary protein —- liver or kidney disease)

  • Kwashiorkor

– in children w/ severe protein deficiency
• fed on cereals once weaned (swollen abdomen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Blood Production

  • Hemopoiesis—production of ___, esp. ____ (RBCs & WBCs)
    • Hemopoietic tissues produce ___

– yolk sac produces ___ for first blood cells
• colonize fetal ___, ___, ___. & ___
– liver stops producing ___ at birth – ____ continues lymphocyte production

A

Blood Production

  • Hemopoiesis—production of blood, esp. formed elements (RBCs & WBCs)
    • Hemopoietic tissues produce blood cells

– yolk sac produces stem cells for first blood cells
• colonize fetal bone marrow, liver, spleen, & thymus
– liver stops producing blood cells at birth – spleen continues lymphocyte production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

___ makes formed elements!

  • Pluripotent stem cells (PPSC)
  • Colony-forming units—specialized ___; produce one class of formed element
  • Myeloid hemopoiesis—blood formation in ___
  • Lymphoid hemopoiesis—blood formation in ___
A

Red bone marrow makes formed elements!

  • Pluripotent stem cells (PPSC)
  • Colony-forming units—specialized stem cells; produce one class of formed element
  • Myeloid hemopoiesis—blood formation in bone marrow
  • Lymphoid hemopoiesis—blood formation in lymphatic organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Erythrocytes

• Functions
– carry ___ from ___ to ___ & pick up ___ from ___ & bring to ___

  • insufficient ___ can kill in minutes due to lack of ___ to ___
A

Erythrocytes

• Functions
– carry O2 from lungs to tissues & pick up CO2 from tissues & bring to lungs

  • insufficient RBCs can kill in minutes due to lack of O2 to tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Erythrocytes: Form & Function

• ___-shaped cell w/ thick ___
– lose nearly all ___ during development!

• lack ___
– ___ fermentation to produce ___

• lack ___ / ___
– no ___ synthesis / ___

-blood type determined by ___ & ___

– ___proteins (spectrin & actin) give membrane ___ & ___

• stretch & ___ as squeezed through ___

A

Erythrocytes: Form & Function

disc-shaped cell w/ thick rim
– lose nearly all organelles during development!

• lack mitochondria
anaerobic fermentation to produce ATP

• lack nucleus / DNA
– no protein synthesis / mitosis

-blood type determined by surface glycoprotein & glycolipids

cytoskeletal proteins (spectrin & actin) give membrane durability & resilience

• stretch & bend as squeezed through small capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Erythrocytes: Form & Function

  • ___ transport
  • ___ delivery to ___ & ___ transport to ___
  • Carbonic anhydrase (CAH) in ___

– produces carbonic acid from ___ & ___

– important for ___ & ___

– H2O + CO2 –> ___ –> H+ + HCO3-

A

Erythrocytes: Form & Function

  • Gas transport
  • O2 delivery to tissues & CO2 transport to lungs
  • Carbonic anhydrase (CAH) in cytoplasm

– produces carbonic acid from CO2 & water

– important for gas transport & pH balance

– H2O + CO2 –> H2CO3 –> H+ + HCO3-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hemoglobin

  • Each Hb molecule:

– 4 ___ —globins
- 4 ___

  • Heme groups

– ___ moiety that binds O2 to ___(Fe2+) at center

  • • Globins—4 ___

– 2α + 2β chains

– 5% ___ in blood is bound to ___ moiety

  • adult vs. fetal hemoglobin
A

Hemoglobin

  • Each Hb molecule:

– 4 protein chains—globins
- 4 heme groups

  • Heme groups

nonprotein moiety that binds O2 to ferrous ion (Fe2+) at center

  • • Globins—4 protein chains

– 2α + 2β chains

– 5% CO2 in blood is bound to globin moiety

  • adult vs. fetal hemoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Erythrocyte Production

  • ___ RBCs produced / second!
  • Avg: ~ ___ mill /microliter (normal)
  • Avg lifespan: ~ ___ days
  • Development: ___ days (reduction in ___, synthesis of ___ , loss of ___)

• First committed cell: erythrocyte ___ unit
– receptors for ___ (___) from ___

• ___ multiply & synthesize ___

• ____ discarded to form ___
– ~__% of circulating RBC = ___

A

Erythrocyte Production

  • 2.5 million RBCs produced / second!
  • Avg: ~ 5 mill /microliter (normal)
  • Avg lifespan: ~ 120 days
  • Development: 3-5 days (reduction in cell size, synthesis of hemoglobin, loss of nucleus)

• First committed cell: erythrocyte colony-forming unit
– receptors for erythropoietin (EPO) from kidneys

Erythroblasts multiply & synthesize hemoglobin

Nucleus discarded to form reticulocyte
– ~1% of circulating RBC = reticulocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Misuse …

• “… growth hormone, cortisone, EPO, steroids and testosterone.”

causes more ___ production –> more ___ to get to ___ —> better ___

A

Misuse …

• “… growth hormone, cortisone, EPO, steroids and testosterone.”

causes more blood cell production –> more O2 to get to muscles —> better performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Iron Metabolism

• ___—key nutritional requirement (Hb!)
– lost daily through ___, ___, & ___
• men __ mg/day, women __ mg/day

– low absorption rate requires ___ ~ ___mg/day

A

Iron Metabolism

iron—key nutritional requirement (Hb!)
– lost daily through urine, feces, & bleeding
• men 0.9 mg/day, women 1.7 mg/day

– low absorption rate requires high consumption ~ 5-20 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Erythrocyte Production

• Vitamin ___ & ___
– for ___ in erythropoiesis

• Vitamin ___ & ___
– for ___ synthesizing Hb

A

Erythrocyte Production

• Vitamin B12 & folic acid
– for mitosis in erythropoiesis

• Vitamin C & copper
– for enzymes synthesizing Hb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Erythrocyte Homeostasis

  • Negative feedback control

– drop in RBC count causes ___
– kidney production of EPO stimulates ___
– RBC count ___

  • Stimuli for increasing erythropoiesis

– ___ levels O2 (___)

– high __

– increase in ___

– ___

A

Erythrocyte Homeostasis

  • Negative feedback control

– drop in RBC count causes kidney hypoxemia
– kidney production of EPO stimulates bone marrow
– RBC count increases

  • Stimuli for increasing erythropoiesis

low levels O2 (hypoxemia)

– high altitude

– increase in exercise

emphysema

21
Q

Erythrocyte Death & Disposal

  • RBCs ___ in narrow channels in ___
  • Macrophages in ___: digest & separate ___ from ___

• Globins hydrolyzed into ___

• ___ removed from heme
-heme converted to ____

– biliverdin converted to ___, released into ___

– liver removes ___ & secretes into ___

– bile concentrated in ___: released into ___ intestines; ___ create urobilinogen (___ feces)

A

Erythrocyte Death & Disposal

  • RBCs lyse in narrow channels in spleen
  • Macrophages in spleen: digest & separate heme from globin

• Globins hydrolyzed into amino acids

Iron removed from heme
-heme converted to biliverdin

– biliverdin converted to bilirubin, released into blood

– liver removes bilirubin & secretes into bile

– bile concentrated in gall bladder: released into small intestines; bacteria create urobilinogen (brown feces)

22
Q

Erythrocyte Disorders

  • Polycythemia—excess ___

– Primary polycythemia (polycythemia vera)
• cancer of erythropoietic ___
– ~11 million RBCs/μL; hematocrit 80%
– Secondary polycythemia
• ___, ___, high ___, or ___ conditioning
– ~8 million RBCs/μL

  • Dangers of polycythemia

– increased blood ___, ___, ___ – risk of stroke or ____

A

Erythrocyte Disorders

  • Polycythemia—excess RBCs

– Primary polycythemia (polycythemia vera)
• cancer of erythropoietic cell line
– ~11 million RBCs/μL; hematocrit 80%
– Secondary polycythemia
dehydration, emphysema, high altitude, or physical conditioning
– ~8 million RBCs/μL

  • Dangers of polycythemia

– increased blood volume, pressure, viscosity – risk of stroke or heart failure

23
Q

Anemia

• 3 categories of causes:

1) Inadequate ___ or ___ synthesis
• ___ failure & ___ erythropoietin
• ___ anemia
• pernicious anemia - inadequate vitamin ___
• hypoplastic anemia—___ of erythropoiesis
• aplastic anemia—___ of erythropoiesis

2) Hemorrhagic anemias from ___
3) Hemolytic anemias from ____

• 3 potential consequences
– tissue ___ & ___ (lethargy, short of ___; necrosis of ___)
– blood osmolarity ___, producing ___ edema

– blood viscosity ___ (heart ___, ___ drops – possible ___)

A

Anemia

• 3 categories of causes:

1) Inadequate erythropoiesis or hemoglobin synthesis
kidney failure & insufficient erythropoietin
iron-deficiency anemia
• pernicious anemia - inadequate vitamin B12
• hypoplastic anemia—slowing of erythropoiesis
• aplastic anemia—cessation of erythropoiesis

2) Hemorrhagic anemias from bleeding
3) Hemolytic anemias from RBC destruction

• 3 potential consequences
– tissue hypoxia & necrosis (lethargy, short of breath; necrosis of vital organs)
– blood osmolarity reduced, producing tissue edema

– blood viscosity low (heart races, pressure drops – possible cardiac failure)

24
Q

Sickle-Cell Disease

• Hereditary hemoglobin defects - mostly in people of ___ descent

• Caused by ____, modifies structure of ___ (___)
– differs only on 6th ___ of β chain
– Hb does not bind __ well
– ___ rigid, sticky, pointy
– ___ together, block ___ blood vessels: intense ___
– risks: ___ / ___ failure, ___, or ___

A

Sickle-Cell Disease

• Hereditary hemoglobin defects - mostly in people of African descent

• Caused by recessive allele, modifies structure of hemoglobin (Hb)
– differs only on 6th amino acid of β chain
– Hb does not bind O2 well
RBCs rigid, sticky, pointy
clump together, block small blood vessels: intense pain
– risks: kidney / heart failure, stroke, or paralysis

25
_Blood Types_ * Blood types & transfusion compatibility: dep. on interactions betw/ ___ & \_\_\_ * Karl Landsteiner discovered blood types \_\_\_, \_\_\_, & ___ in 1900 (Nobel Prize 1930) * Blood types based on interactions betw/ ___ & \_\_\_
_Blood Types_ * Blood types & transfusion compatibility: dep. on interactions betw/ **plasma proteins & erythrocytes** * Karl Landsteiner discovered blood types **A, B, & O** in 1900 (Nobel Prize 1930) * Blood types based on interactions betw/ **antigens & antibodies**
26
_Blood Types_ * Antigens – complex molecules on ___ – unique to \_\_\_ • distinguish self from \_\_\_ * ___ generate an immune response * agglutinogens= antigens on ___ : basis for \_\_\_ * Antibodies – proteins (γ globulins) secreted by \_\_\_\_ • part of immune response to \_\_\_\_ * bind to \_\_\_, mark for \_\_\_ * forms \_\_\_–\_\_\_ complexes * \_\_\_\_= antibodies in plasma: cause ___ mismatch * Agglutination – ___ molecule binding to ___ – causes ___ of RBCs * ___ antigens = agglutinogens – antigen ___ & \_\_\_ – determined by ___ moieties * ___ = agglutinins – in \_\_\_ – anti-\_\_\_ & anti-\_\_\_
_Blood Types_ * Antigens – complex molecules on **cell membrane surface** – unique to **individual** • distinguish self from **foreign matter** * **foreign antigens** generate an immune response * agglutinogens= antigens on **RBC surface** : basis for **blood typing** * Antibodies – proteins (γ globulins) secreted by **plasma cells** • part of immune response to **foreign matter** * bind to **antigens**, mark for **destruction** * forms **antigen–antibody** complexes * **agglutinins**= antibodies in plasma: cause **transfusion** mismatch * Agglutination – **antibody** molecule binding to **antigens** – causes **clumping** of RBCs * **RBC** antigens = agglutinogens – antigen **A & B** – determined by **carbohydrate** moieties * **Antibodies** = agglutinins – in **plasma** – anti**-A** & anti-**B**
27
_ABO Group_ • ABO blood type determined by ___ / ___ of ___ (agglutinogens) on \_\_\_ – blood type A person has ___ antigens – blood type B person has ___ antigens – blood type AB has ____ antigens – blood type O person has ___ antigen * most common: type ___ (45%) * rarest: type ___ (4%)
_ABO Group_ • ABO blood type determined by **presence / absence** of **antigens** (agglutinogens) on **RBCs** – blood type A person has **A** antigens – blood type B person has **B** antigens – blood type AB has **A & B** antigens – blood type O person has **neither** antigen * most common: type **O** (45%) * rarest: type **AB** (4%)
28
_ABO Group_ * Antibodies (\_\_\_); anti-\_\_\_ & anti-\_\_\_ * If type A or O, have ___ agglutinins * If type B or O, have ___ agglutinins * If type \_\_\_, have neither
_ABO Group_ * Antibodies (**agglutinins**); anti-**A** & anti-**B** * If type A or O, have **anti-B** agglutinins * If type B or O, have **anti-A** agglutinins * If type **AB**, have neither
29
_ABO Group_ * Agglutination – each ___ can attach to ___ on several different ___ at same time – responsible for\_\_\_\_ reaction – agglutinated RBCs block ___ & hemolyze – Hb blocks *\_\_\_* tubules, causes \_\_\_ * Universal \_\_\_ – Type \_\_: most common blood type – lacks RBC \_\_\_\_, but… – ___ may have anti-A & anti-B Abs against recipient’s \_\_\_ • give packed cells (minimal \_\_\_) • Universal \_\_\_ – Type\_\_\_: rarest blood type – no ___ nor ___ Abs
_ABO Group_ * Agglutination – each **antibody** can attach to **antigens** on several different **RBCs** at same time – responsible for **mismatched transfusion** reaction – agglutinated RBCs block **small blood vessels** & hemolyze – Hb blocks **kidney** tubules, causes **renal failure** * Universal **donor** – Type **O**: most common blood type – lacks RBC **antigens**, but… – **plasma** may have anti-A & anti-B Abs against recipient’s **RBCs** • give packed cells (minimal **plasma**) • Universal **recipient** – Type **AB**: rarest blood type – no **anti-A** nor **anti-B** Abs
30
_Rh Group_ * Rh (\_\_, \_\_, \_\_) agglutinogens discovered in rhesus monkey in 1940 – Rh D = most \_\_\_; patient called Rh+ if ___ on RBCs * ___ agglutinins not normally present – Form in ___ individuals exposed to ___ blood • ___ woman w/ ___ fetus or transfusion of ___ blood • no problems w/ first pregnancy * If Rh-mother formed Abs & is pregnant w/ second Rh+ child … – ___ antibodies can cross placenta * Prevention – RhoGAM given to pregnant ___ women • binds fetal ___ in her blood so she will not form \_\_\_
_Rh Group_ * Rh **(C, D, E)** agglutinogens discovered in rhesus monkey in 1940 – Rh D = most **reactive**; patient called Rh+ if **D antigen** on RBCs * **Anti-D** agglutinins not normally present – Form in **Rh-** individuals exposed to **Rh+** blood • **Rh-** woman w/ **Rh+** fetus or transfusion of **Rh+** blood • no problems w/ first pregnancy * If Rh- mother formed Abs & is pregnant w/ second Rh+ child … – **Anti-D** antibodies can cross placenta * Prevention – RhoGAM given to pregnant **Rh-** women • binds fetal **agglutinogens** in her blood so she will not form **anti-D antibodies**
31
_Hemolytic Disease of Newborns (HDN)_ • ___ antibodies attack fetal blood causing severe \_\_\_
_Hemolytic Disease of Newborns (HDN)_ • **Rh** antibodies attack fetal blood causing severe **anemia**
32
_Leukocytes: Form & Function_ * least \_\_\_formed element (5,000-10,000 WBCs/µL) * protect against \_\_\_ * conspicuous \_\_\_ * time in blood brief before migrating to other \_\_\_\_ • Granules: – all WBCs have ___ = _nonspecific_ (azurophilic) granules: inconspicuous so cytoplasm looks \_\_\_ – Granulocytes have ___ granules: ___ lysosomes that stain in specific ways...
_Leukocytes: Form & Function_ * least **abundant** formed element (5,000-10,000 WBCs/µL) * protect against **infectious microorganisms** * conspicuous **nucleus** * time in blood brief before migrating to other **tissues** • Granules: – all WBCs have **lysosomes** = nonspecific (azurophilic) granules: inconspicuous so cytoplasm looks **clear** – Granulocytes have **specific** granules: **protein-packed** lysosomes that stain in specific ways...
33
_Types of Leukocytes_ • Granulocytes – ____ (60-70%): polymorphonuclear • ___ barely visible – ___ (2-4%) • ___ granules; ___ nucleus – ___ (\< 0.5%) • large, abundant, ___ granules (obscure \_\_\_-shaped nucleus) • Agranulocytes – ___ (25-33%) • ___ round, uniform dark ___ nucleus – Monocytes (3-8%) • largest \_\_\_; \_\_\_/horseshoe-shaped nucleus
_Types of Leukocytes_ • Granulocytes – **Neutrophils** (60-70%): polymorphonuclear • **granules** barely visible – **Eosinophils** (2-4%) • **large red** granules; **bi-lobed** nucleus – **Basophils** (\< 0.5%) • large, abundant, **violet** granules (obscure **S**-shaped nucleus) • Agranulocytes – **Lymphocytes** (25-33%) • **BIG** round, uniform dark **violet** nucleus – Monocytes (3-8%) • largest **WBC; kidney**/horseshoe-shaped nucleus
34
_Granulocytes: Functions_ • Neutrophils—increased in ___ infections – phagocytosis of \_\_\_ • Eosinophils—increased in ____ infections, \_\_\_, collagen diseases – in \_\_\_, few in \_\_\_\_– release ____ to destroy large parasites • Basophils—increased in ___ – secrete ___ (vasodilator): speeds flow of blood to ___ – secrete ___ (anticoagulant): promotes mobility of other \_\_\_\_
_Granulocytes: Functions_ • Neutrophils—increased in **bacterial** infections – phagocytosis of **bacteria** • Eosinophils—increased in **parasitic** infections, **allergies**, collagen diseases – in **mucous membranes**, few in **blood** – release **enzymes** to destroy large parasites • Basophils—increased in **v****arious conditions** – secrete **histamine** (vasodilator): speeds flow of blood to **injured area** – secrete **heparin** (anticoagulant): promotes mobility of other **WBCs**
35
_Agranulocytes: Functions_ * Lymphocytes—increased in ___ infections & ___ responses – destroy \_\_\_(\_\_\_, \_\_\_, & virally infected cells) – “present” ___ to activate other ___ cells – coordinate ___ of other immune cells – secrete ___ & provide \_\_\_\_ * Monocytes—increased numbers in ___ infections & \_\_\_ – leave ___ & transform into \_\_\_ -phagocytize ___ & \_\_\_ -“present” ___ to activate other ___ cells—antigen-presenting cells (APCs)
_Agranulocytes: Functions_ * Lymphocytes—increased in **diverse** infections & **immune** responses – destroy **cells (cancer, foreign**, & virally infected cells) – “present” **antigens** to activate other immune cells – coordinate **actions** of other immune cells – secrete **antibodies** & provide **immune memory** * Monocytes—increased numbers in **viral** infections & **inflammation** – leave **blood** & transform into **macrophages** -phagocytize **pathogens & debris** -“present” **antigens** to activate other **immune** cells—antigen-presenting cells (APCs)
36
_Leukocyte Life Cycle_ * Leukopoiesis—production of \_\_\_ – ___ (PPSCs) - Myeloblasts—form \_\_\_, \_\_\_, \_\_\_ - Monoblasts—form \_\_\_ - Lymphoblasts form all \_\_\_ * ___ : stores & releases granulocytes & monocytes * Circulating WBCs \_\_\_ – ___ leave in 8 hrs, live ~ 5 days – ___ leave in 20 hrs, transform into macrophages, live years – ___ provide long-term immunity (decades), being continuously recylcled : blood --\> ___ --\> ___ --\> blood
_Leukocyte Life Cycle_ * Leukopoiesis—production of **WBCs** – **Pluripotent stem cells** (PPSCs) - Myeloblasts—form **neutrophils, eosinophils, basophils** - Monoblasts—form **monocytes** - Lymphoblasts form all **lymphocytes** * **Red bone marrow**: stores & releases granulocytes & monocytes * Circulating WBCs **do not stay in blood** – **granulocytes** leave in 8 hrs, live ~ 5 days – **monocytes** leave in 20 hrs, transform into macrophages, live years – **lymphocytes** provide long-term immunity (decades), being continuously recycled: blood --\> **tissues --\> lymph** --\> blood
37
_Leukocyte Disorders_ * Leukopenia— ___ count: \< \_\_\_WBCs/µL – causes: ___ , \_\_\_, some viral diseases – effects: elevated risk of \_\_\_ * Leukocytosis—\_\_\_count: \> \_\_\_WBCs/µL – causes: infection, \_\_\_, \_\_\_ * Differential WBC count: % of ___ WBC count for each type of \_\_\_ * Leukemia—cancer of \_\_\_; extraordinarily ___ number of circulating ___ & their precursors – Myeloid leukemia: uncontrolled ___ production – Lymphoid leukemia: uncontrolled ___ or ___ production – acute leukemia: appears \_\_\_, progresses \_\_\_ – chronic leukemia: can go ___ for months, survival time __ years (untreated) – effects: impaired \_\_\_, therefore opportunistic \_\_\_; impaired production of \_\_\_, \_\_\_
_Leukocyte Disorders_ * Leukopenia— **low** **WBC** count: \< **5000** WBCs/µL – causes: **radiation, poisons**, some viral diseases – effects: elevated risk of **infection** * Leukocytosis—**high WBC** count: \> **10,000** WBCs/µL – causes: infection, **allergy, dehydration** * Differential WBC count: % of **total** WBC count for each type of **leukocyte** * Leukemia—cancer of **hemopoietic tissue**; extraordinarily **high** number of circulating **leukocytes** & their precursors – Myeloid leukemia: uncontrolled **granulocyte** production – Lymphoid leukemia: uncontrolled **lymphocyte** or **monocyte** production – acute leukemia: appears **suddenly**, progresses **rapidly** – chronic leukemia: can go **undetected** for months, survival time **3** years (untreated) – effects: impaired **function**, therefore opportunistic **infection**s; impaired production of **RBCs, platelet**
38
_Complete Blood Count_ * Hematocrit - RBC % (\_\_\_% is normal) - Hb \_\_\_ - total count for cells & platelets - differential ___ count - RBC ___ & ___ concentration per RBC
_Complete Blood Count_ * Hematocrit - RBC % (**45**% is normal) - Hb **concentration** - total count for **cells & platelets** - differential WBC count - RBC **size** & **hemoglobin** concentration per RBC
39
_Platelets & Hemostasis—Control of Bleeding_ * Hemostasis—\_\_\_ of bleeding – hemorrhage = ___ bleeding * 3 hemostatic mechanisms – vascular \_\_\_ – ___ formation – \_\_\_\_(coagulation) * ___ play important role in all 3!
_Platelets & Hemostasis—Control of Bleeding_ * Hemostasis—**cessation** of bleeding – hemorrhage = **excessive** bleeding * 3 hemostatic mechanisms – vascular **spasm** – **platelet plug** formation – **blood clotting** (coagulation) * **Platelets** play important role in all 3!
40
_Platelet Form & Function_ * Platelets—small fragments of \_\_\_ – yet complex \_\_\_structure, \_\_\_\_, & open ___ system * Normal platelet count =\_\_\_\_ platelets/ µL * Functions – secrete ___ - help reduce \_\_\_ – form ___ to seal small breaks – secrete ___ (clotting factors) to promote clotting – initiate formation of \_\_\_ – chemically attract ___ & ___ to ___ sites – phagocytize \_\_\_\_ – secrete ____ - stimulate mitosis to repair \_\_\_
_Platelet Form & Function_ * Platelets—small fragments of **megakaryocytes** – yet complex **internal** structure, **granules**, & open **canalicular** system * Normal platelet count =**130,000-400,000** platelets/ µL * Functions – secrete **vasoconstrictors** - help reduce **blood loss** – form **platelet plugs** to seal small breaks – secrete **procoagulants** (clotting factors) to promote clotting – initiate formation of **clot-dissolving enzyme** – chemically attract **neutrophils & monocytes** to **inflammation** sites – phagocytize **bacteria** – secrete **growth factors** - stimulate mitosis to repair **blood vessel**
41
_Platelet Production_ * Thrombopoiesis – ___ become ____ (receptors for thrombopoietin) * Megakaryoblasts – repeatedly replicate ___ w/out \_\_\_\_ – form gigantic 100 µm cells (\_\_\_\_) * Megakaryocytes—in ____ adjacent to \_\_\_ – tendrils of ___ (proplatelets) protrude into \_\_\_: blood flow splits off fragments called \_\_\_ – circulate ___ days; 40% stored in \_\_\_
_Platelet Production_ * Thrombopoiesis – s**tem cells** become **megakaryoblasts** (receptors for thrombopoietin) * Megakaryoblasts – repeatedly replicate **DNA** w/out **dividing** – form gigantic 100 µm cells (**megakaryocytes**) * Megakaryocytes—in **bone marrow** adjacent to **blood sinusoids** * – tendrils of **cytoplasm** (proplatelets) protrude into **blood sinusoids**: blood flow splits off fragments called **platelets** * – circulate **10** days; 40% stored in **spleen**
42
_Hemostasis_ 1. ____ —prompt constriction of broken vessel – most immediate protection against \_\_\_ – pain & smooth muscle injury prompt \_\_\_ – platelets release ___ (vasoconstrictor) – buys time for other 2 clotting pathways 2. \_\_\_\_ Normally, … ___ (platelet repellant) coats endothelium – But… – ___ exposes collagen – platelets grow __ - stick to ___ ; ___ contract & draw walls of vessel together forming \_\_\_ – Platelets \_\_\_, release: * - ___ - vasoconstricts * Thromboxane A2 (eicosanoid) - promotes platelet \_\_\_, \_\_\_, & \_\_\_ – \_\_\_\_\_feedback cycle active until break in small vessel seals 3. ___ (clotting) —last / most effective defense against \_\_\_ – conversion of ___ to ___ threads to form framework of \_\_\_ * Procoagulants (clotting factors)—usually made by \_\_\_; present in \_\_\_ * – activate one factor, it activates next … ___ cascade * Extrinsic pathway – factors released by ____ begin cascade * Intrinsic pathway – factors in ___ begin cascade (platelet \_\_\_)
_Hemostasis_ 1. **Vascular spasm** —prompt constriction of broken vessel – most immediate protection against **blood loss** – pain & smooth muscle injury prompt **quick constriction** – platelets release **serotonin** (vasoconstrictor) – buys time for other 2 clotting pathways 2. **Platelet plug formation** Normally, … **Prostacyclin** (platelet repellant) coats endothelium – But… – **broken vessel** exposes collagen – platelets grow **pseudopods** - stick to **damaged vessel**; **pseudopods** contract & draw walls of vessel together forming **platelet plug** – Platelets **degranulate**, release: * - **Serotonin** - vasoconstricts * Thromboxane A2 (eicosanoid) - promotes platelet **aggregation, degranulation, & vasoconstriction** – **Positive** feedback cycle active until break in small vessel seals 3. **Coagulation** (clotting) —last / most effective defense against **bleeding** – conversion of **fibrinogen** to **fibrin** threads to form framework of **clot** * Procoagulants (clotting factors)—usually made by **liver**; present in **plasma** * – activate one factor, it activates next … **reaction** cascade * Extrinsic pathway – factors released by **damaged tissues** begin cascade * Intrinsic pathway – factors in **blood** begin cascade (platelet **degranulation**)
43
_Coagulation_ * Extrinsic pathway – initiated by tissue **\_\_\_** (factor \_\_\_) from \_\_\_ – combines w/ \_\_\_to activate \_\_ * Intrinsic pathway – initiated by Factor ___ from \_\_\_ – cascade to factor __ to ___ to ___ to \_\_ * ___ required!! Reaction Cascade in \_\_\_ • Rapid clotting—each activated cofactor activates more ___ in next step of sequence
_Coagulation_ * Extrinsic pathway – initiated by tissue **thromboplastin** (factor **III**) from **damaged tissue** – combines w/ **VII** to activate **X** * Intrinsic pathway – initiated by Factor **XII** from **platelets** – cascade to factor **XI** to **IX** to **VIII** to **X** * **Calcium** required!! Reaction Cascade in **Clotting** • Rapid clotting—each activated cofactor activates more **molecules** in next step of sequence
44
_Completion of Coagulation_ * Activation of factor __ – activates __ activator * ___ activator – converts prothrombin to \_\_\_ * ___ – converts ___ to fibrin • Positive feedback—\_\_\_ speeds up formation of ___ activator
_Completion of Coagulation_ * Activation of factor **X** – activates **prothrombin** activator * **Prothrombin** activator – converts prothrombin to **t****hrombin** * **Thrombin** – converts **f****ibrinogen** to fibrin • Positive feedback—**thrombin** speeds up formation of **prothrombin** activator
45
_Fate of Clots_ * Clot retraction occurs w/in ___ min. * Platelet-derived growth factor – stimulates fibroblasts & smooth muscle cell mitosis – repair \_\_ * Fibrinolysis— \_\_\_of clot – Factor ___ speeds up formation of ___ enzyme - ___ converts ____ into plasmin = \_\_\_-dissolving enzyme
_Fate of Clots_ * Clot retraction occurs w/in **30** min. * Platelet-derived growth factor – stimulates fibroblasts & smooth muscle cell mitosis – repair **damaged vessel** * Fibrinolysis—**dissolution** of clot – Factor **XII** speeds up formation of **kallikrein** enzyme – **kallikrein** converts **plasminogen** into plasmin = **fibrin**-dissolving enzyme
46
_Prevention of Inappropriate Clotting_ * Platelet repulsion – platelets do not adhere to \_\_\_-coated \_\_\_ * ___ dilution – by rapidly flowing blood * Natural anticoagulants – Heparin (from \_\_\_) interferes w/ formation of ___ activator – Antithrombin (from \_\_\_) deactivates ___ before it acts on \_\_\_
_Prevention of Inappropriate Clotting_ * Platelet repulsion – platelets do not adhere to **prostacyclin**-coated **endothelium** * **Thrombin** dilution – by rapidly flowing blood * Natural anticoagulants * – Heparin (from **basophils**) interferes w/ formation of **prothrombin** activator – Antithrombin (from **liver**) deactivates **thrombin** before it acts on **fibrinogen**
47
_Clotting Disorders_ * ___ of any clotting factor can shut down coagulation cascade * Hemophilia—family of ___ diseases characterized by ___ of factor * Sex-linked ____ (\_\_ chromosome) – Hemophilia A missing factor ___ (83% of cases) – Hemophilia B missing factor ___ (15%) - Hemophilia C missing factor ___ (autosomal) * ____ causes bleeding & excruciating pain – ___ in muscles – transfusion of ___ or purified clotting factors – (Factor VIII produced by transgenic \_\_\_) * Thrombosis—abnormal clotting in \_\_\_\_ – thrombus = \_\_\_ - Embolus—thrombus that ___ in blood – pulmonary embolism: clot from ___ may travel to \_\_\_ • Infarction (\_\_\_ death) may occur if clot blocks blood supply to ___ (MI) or ___ (stroke)
_Clotting Disorders_ * **Deficiency** of any clotting factor can shut down coagulation cascade * Hemophilia—family of **hereditary** diseases characterized by **deficiencies** of factor * Sex-linked **recessive** (**X** chromosome) – Hemophilia A missing factor **VIII** (83% of cases) – Hemophilia B missing factor **IX** (15%) * Hemophilia C missing factor **XI** (autosomal) * **Physical exertion** causes bleeding & excruciating pain – **hematomas** in muscles – transfusion of **plasma** or purified clotting factors – (Factor VIII produced by transgenic **bacteria**) * Thrombosis—abnormal clotting in **unbroken vessel** – thrombus = **clot** - Embolus—thrombus that **travels** in blood – pulmonary embolism: clot from **legs** may travel to **lungs** • Infarction (**tissue** death) may occur if clot blocks blood supply to **heart** (MI) or **brain** (stroke)
48
_Clinical Management of Clotting_ Goal—prevent formation of ___ or ___ existing clots 1. Preventing clots – Vitamin ___ required for formation of clotting factors • coumarin, warfarin (coumadin) = \_\_\_ – ___ suppresses thromboxane A2 – others discovered in animal research - ___ from leeches since 1884 – inhibits thrombin 2. Dissolving clots – Streptokinase: enzyme from ___ bacteria • dissolve clots in \_\_\_vessels – Tissue Plasminogen Activator (TPA): ___ & more specific - \_\_\_: from giant Amazon leech
_Clinical Management of Clotting_ Goal—prevent formation of **clots** or **dissolve** existing clots 1. Preventing clots – Vitamin **K** required for formation of clotting factors • coumarin, warfarin (coumadin) = **vitamin K antagonists** – **a****spirin** suppresses thromboxane A2 – others discovered in animal research - **hirudin** from leeches since 1884 – inhibits thrombin 2. Dissolving clots – Streptokinase: enzyme from **S****treptococci** bacteria • dissolve clots in coronary vessels – Tissue Plasminogen Activator (TPA): **faster** & more specific – **hementin**: from giant Amazon leech